News
QICCD 2020: Diagnosis and Treatment of Cardiovascular Disease
Dr. Kunlin Cao, President of Keya Medical R&D, participated in the Cardiovascular Disease Imaging Forum at QICCD 2020 alongside Dr. Pengfei Zhang of Shangdong University.
Keya Medical Presents at the Second Congress of China AI in Medical Imaging Conference
Dr. Kunlin Cao delivered a keynote address at the China AI in Medical Imaging Conference on Keya Medical’s experience bringing AI-powered medical imaging solutions to clinical use.
Innovation Fast and Slow: The Case for Coronary CT Angiography
Recent research demonstrates applications for CCTA to be used as the default test for evaluating patients with stable chest pain.
Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award
On Sept. 18, Keya Medical was recognized as the winner of of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.
Keya Medical Delivers Academic Lecture at Northern Jiangsu People’s Hospital
On Sept. 10, Keya Medical was invited to deliver an academic lecture to more than 130 imaging departments in honor of the newly established Northern Jiangsu People’s Hospital Medical Imaging Alliance.
QICC 2020: Clinical Significance and Research Progress of Non-invasive CT-FFR
During QICC 2020, Dr. Xinyang Hu delivered a special lecture on the clinical significance of non-invasive CT-FFR.
ESC Congress 2020: Cardiovascular Imaging AI Applications
The European Society of Cardiology (ESC) Congress 2020 revealed opportunities and challenges in cardiovascular imaging AI.
ESC Updated Guidelines on Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
The European Society of Cardiology published new clinical practice guidelines on managing acute coronary syndromes in patients.
Keya Medical Raises Over $20 Million in Series B+ Financing Round
Keya Medical announced on Aug. 13 that it has raised over $20 million in Series B+ funding.
Keya Medical Partners with Luohe Sixth People’s Hospital
DeepVessel FFR was successfully implemented in Luohe Sixth People’s Hospital.
NMPA Regulatory Policy for Medical AI Solutions
The National Medical Products Administration (NMPA) in China has published new documents regarding the approval of medical AI products.
COVID-19 Research Results Published in Radiology
On March 20, the research results of Keya Medical’s COVID-19 AI Assisted Diagnosis algorithm were published in the peer-reviewed journal Radiology.
